Atlas Trials

ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma

Clinical trial NCT03888859 · COMPLETED

Trial details

NCT number
NCT03888859
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Hepatocellular CarcinomaLiver CancerLiver NeoplasmsMetastatic Liver Cancer
Start date
2017-12-06
Primary completion
2019-04-13
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.